Sartorius Stedim Biotech Stock
Stocks
DIM
FR0013154002
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Other stock markets
|
After hours 15:59:55 | |||
| 167.30 EUR | +2.01% |
|
166.95 | -0.21% |
| 06:57am | SARTORIUS STEDIM BIOTECH : JP Morgan keeps its Buy rating | ZD |
| 12:20am | Sartorius Stedim Biotech S.A., H1 2026 Earnings Call, Jul 23, 2026 |
| Market Cap | 16.28B 18.53B 15.14B 13.89B 26.1B 1,785B 26.5B 180B 70.23B 877B 69.57B 68.07B 3,034B | P/E 2026 * |
42.9x | P/E 2027 * | 32.2x |
|---|---|---|---|---|---|
| Enterprise Value | 18.27B 20.8B 16.99B 15.59B 29.29B 2,003B 29.75B 202B 78.82B 985B 78.09B 76.4B 3,405B | EV / Sales 2026 * |
5.84x | EV / Sales 2027 * | 5.18x |
| Free-Float |
28.47% | Yield 2026 * |
0.5% | Yield 2027 * | 0.63% |
Last Transcript: Sartorius Stedim Biotech
| 1 day | +2.01% | ||
| 1 week | -10.73% | ||
| Current month | -7.87% | ||
| 1 month | +2.51% | ||
| 3 months | +5.95% | ||
| 6 months | -18.79% | ||
| Current year | -20.33% |
| 1 week | 158.9 | 187.4 | |
| 1 month | 158.9 | 190.8 | |
| Current year | 150 | 224 | |
| 1 year | 150 | 224 | |
| 3 years | 139.1 | 287.8 | |
| 5 years | 139.1 | 551 | |
| 10 years | 50.13 | 551 |
| Manager | Title | Age | Since |
|---|---|---|---|
René Fáber
CEO | Chief Executive Officer | 51 | 2023-03-27 |
| Chief Tech/Sci/R&D Officer | 61 | 2011-09-07 | |
Petra Müller
IRC | Investor Relations Contact | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 65 | 2015-04-06 | |
Susan Dexter
BRD | Director/Board Member | 69 | 2015-04-06 |
Lothar Kappich
BRD | Director/Board Member | 69 | 2017-09-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/17/25 | Sell | Company | 750,000 | 0.7706% | ||
| 2/16/24 | Buy | Chief Executive Officer | 1,716,739 | 1.8624% | ||
| 3/2/22 | Sell | Company | 200,442 | 0.2174% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.01% | -10.73% | -3.21% | -38.49% | 18.14B | ||
| +2.29% | +2.36% | -17.97% | -10.09% | 175B | ||
| +1.46% | +0.01% | -9.87% | -6.25% | 105B | ||
| +1.58% | +0.65% | +6.69% | +61.86% | 59.35B | ||
| -1.13% | -1.96% | +32.11% | +56.38% | 50.71B | ||
| +2.22% | -1.14% | -14.85% | -44.15% | 42.15B | ||
| +2.98% | -2.61% | - | - | 31.82B | ||
| +1.50% | -6.67% | -17.52% | -43.99% | 27.2B | ||
| -7.67% | -8.39% | +17.59% | -12.73% | 25.11B | ||
| +1.63% | -1.73% | -5.80% | -7.80% | 20.53B | ||
| Average | +0.66% | -4.33% | -1.43% | -5.03% | 55.55B | |
| Weighted average by Cap. | +1.23% | -1.87% | -5.73% | -0.25% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 3.13B 3.56B 2.91B 2.67B 5.02B 343B 5.1B 34.56B 13.5B 169B 13.38B 13.09B 583B | 3.48B 3.96B 3.23B 2.97B 5.58B 381B 5.66B 38.41B 15.01B 188B 14.87B 14.55B 648B |
| Net income | 367M 418M 342M 314M 589M 40.29B 598M 4.06B 1.59B 19.81B 1.57B 1.54B 68.48B | 486M 553M 452M 414M 779M 53.24B 791M 5.36B 2.09B 26.17B 2.08B 2.03B 90.5B |
| Net Debt | 1.99B 2.27B 1.85B 1.7B 3.19B 218B 3.24B 22B 8.59B 107B 8.51B 8.33B 371B | 1.74B 1.98B 1.62B 1.49B 2.79B 191B 2.83B 19.22B 7.51B 93.81B 7.44B 7.28B 324B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-24 | €167.30 | +2.01% | 105,317 |
| 26-07-23 | €164.00 | -6.45% | 215,014 |
| 26-07-22 | €175.30 | +5.22% | 134,439 |
| 26-07-21 | €166.60 | -7.55% | 213,161 |
| 26-07-20 | €180.20 | -2.96% | 55,079 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- DIM Stock
Select your edition
All financial news and data tailored to specific country editions





















